East London experience with enteric fever 2007-2012

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Dave, Jayshree ^a   Millar, Michael ^b   Maxeiner, Horst ^a   Freedman, Joanne ^a   Meade, Rachel ^a   Rosmarin, Caryn ^b   Jordan, Matthew ^a   Andrews, Nick ^a   Holliman, Richard ^a   Sefton, Armine ^c  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b ROYAL LONDON HOSPITAL   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; AMIKACIN; AZITHROMYCIN; BILIRUBIN; C REACTIVE PROTEIN; CEFTRIAXONE; CIPROFLOXACIN; LIVE VACCINE; TYPHOID VACCINE; BIOLOGICAL MARKER;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; BILIRUBIN BLOOD LEVEL; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; EMERGENCY MEDICINE; FEMALE; HEALTH CARE COST; HOSPITALIZATION; HUMAN; INFANT; LENGTH OF STAY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; PUBLIC HEALTH SERVICE; RETROSPECTIVE STUDY; SALMONELLA ENTERICA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHI; SALMONELLA PARATYPHI C; TRAVEL; TYPHOID FEVER; UNITED KINGDOM; BLOOD; DEMOGRAPHY; ECONOMICS; HOSPITAL; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PRESCHOOL CHILD; RECURRENT DISEASE; RISK FACTOR; SALMONELLA ENTERICA SEROVAR PARATYPHI A; SALMONELLA ENTERICA SEROVAR TYPHI; VACCINATION; YOUNG ADULT;

SALMONELLA ENTERICA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHI; SALMONELLA TYPHI;

ADOLESCENT; ADULT; AGED; BIOMARKERS; CHILD; CHILD, PRESCHOOL; DEMOGRAPHY; FEMALE; HOSPITALS; HUMANS; INFANT; LENGTH OF STAY; LONDON; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SALMONELLA PARATYPHI A; SALMONELLA TYPHI; TRAVEL; TYPHOID FEVER; VACCINATION; YOUNG ADULT;

EID: 84925652486     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0120926     Document Type: Article

References (26)

1. Balasegaram S, Potter AL, Grynszpan D, Barlow S, Behrens RH, Lighton L et al, Typhoid and Paratyphoid Reference Group, Health Protection Agency, London, England. J Infect. 2012; 65(3):197-213. doi: 10.1016/j.jinf.2012.05.005 PMID: 22634599
2. Buckle GC, Fischer Walker CL, Black RE. Typhoid fever and paratyphoid fever: Systematic review to estimate global morbidity and mortality for 2010. J Glob Health. 2012; 2:1-9.
3. Crump JA, Luby SP, Mintz ED.The global burden of typhoid fever. Bull World Health Organ. 2004; 82:346-353. PMID: 15298225
4. Ivanoff B, Levine MM, Lambert PH. Vaccination against typhoid fever: present status. Bull World Health Organ. 1994; 72:957-971. PMID: 7867143
5. Ochiai RL, Acosta CJ, Danovaro-Holliday MC, Baiqing D, Bhattacharya SK, Agtini MD et al. A study of typhoid fever in five Asian countries: disease burden and implications for controls. Bull World Health Organ. 2008; 86:260-268. PMID: 18438514
6. Crump JA, Mintz ED.Global trends in typhoid and paratyphoid fever. Clin Infect Dis. 2010; 50:241-246. doi: 10.1086/649541 PMID: 20014951
7. Public Health England. Enteric Fever (typhoid and paratyphoid) in England, Wales and Northern Ireland: 2012. Public Health England. 2014. Available: http://webarchive.nationalarchives.gov.uk/ 20140714084352/http://www.hpa.org.uk/webc/HPAwebFile/HPAweb-C/1317140635485. Accessed 17 January 2014.
8. Reddy S, Rangaiah J, Addiman S, Wareham D, Wilson P, Sefton A. Epidemiology, antibiotic resistance trends and the cost of enteric fever in East London, 2005-2010. Travel Med Infect Dis. 2011; 9:206-212. doi: 10.1016/j.tmaid.2011.03.003 PMID: 21636325
9. Office of National Statistics. 2011. Available: http://www.nomisweb.co.uk/census/2011/ks201ew. Accessed 8 July 2014.
10. Addiman S, Maimaris W, Thomas HL, White G, Lawrence J, Balasegaram S Public health management of Salmonella Typhi/Paratyphi case and contact screening: lessons from North London. Public Health. 2013; 127:207-213. doi: 10.1016/j.puhe.2012.12.015 PMID: 23433577
11. Health Protection Agency. Enhanced surveillance of enteric fever. 2014. Available: http://webarchive. nationalarchives.gov.uk/20140714084352/http://www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/TravelHealth/GeneralInformation/trav30Enhancedsurveillanceofentericfever/. Accessed 9 July 2014.
12. Health Protection Agency Migrant Health: Infectious diseases in non-UK born populations in England, Wales and Northern Ireland. An update to the baseline report-2011. Health Protection Agency Centre for Infections, London. 2011. Available: http://www.sepho.org.uk/viewResource.aspx?id=14340. Accessed 9 July 2014.
13. Health Protection Agency. Pilot of enhanced surveillance of enteric fever in England, Wales, and Northern Ireland, 1 May 2006 to 30 April 2007.2008. Available: http://webarchive.nationalarchives.gov.uk/ 20140714084352/http://www.hpa.org.uk/web/HPAweb&HPAwebStandard/HPAweb-C/ 1206575041900. Accessed 9 July 2014.
14. Office for National Statistics. International Passenger Survey 2012. Crown Copyright;2013. [Bespoke dataset supplied to Public Health England, Travel and Migrant Health Section].
15. Parry CM, Hien TT, Dougan G, White NJ, Farrar JJ.Typhoid Fever. N Engl J Med. 2002; 347:1770-1782. PMID: 12456854
16. Mandell GL, Bennett JE, Dolin R.Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 7th ed. Philadelphia: Churchill Livingston Elselvier;2010. doi: 10.1056/NEJMoa1304839. Two PMID: 24450891
17. Background document: The diagnosis, treatment and prevention of typhoid fever. Geneva;WHO:2003.
18. Barrett FC, Knudsen JD, Johansen IS. Cases of typhoid fever in Copenhagen region: a retrospective study of presentation and relapse. BMC Res Notes. 2013; 6:315-319. doi: 10.1186/1756-0500-6-315 PMID: 23937856
19. Maskey AP, Day JN, Phung QT, Thwaites GE, Campbell JI, Zimmerman M, et al. Salmonella enterica Typhi and Paratyphi A cause indistinguishable clinical syndromes in Kathmandu, Nepal. Clin Infect Dis. 2006; 42:1247-1253. PMID: 16586383
20. Meltzer E, Sadik C, Schwartz E. Enteric fever in Israeli travellers: a nationwide study. J Travel Med. 2005; 12:275-281. PMID: 16256052
21. Gilman RH, Terminel M, Levine MM, Hernandez-Mendoza P, Hornick RB. Relative efficacy of blood, urine, rectal swab, bone-marrow, and rose-spot cultures for recovery of Salmonella typhi in typhoid fever. Lancet. 1975; 1:1211-1213. PMID: 48834
22. Public Health England. Typhoid: the green book, chapter 33. Public Health England. 2013. Available: https://www.gov.uk/government/publications/typhoid-the-green-book-chapter-33. Accessed 14 July 2014.
23. Health Protection Agency. Typhoid fever vaccine recalled. 2012. Available: http://webarchive.nationalarchives.gov.uk/20140714084352/http://www.hpa.org.uk/NewsCentre/NationalPressReleases/2012PressReleases/121009Typhoidvaccinerecall/. Accessed 12 May 2014.
24. Waddington C, Darton T, Pollard A. The challenge of enteric fever. J Infect. 2014; 68:38-50.
25. Health Protection Agency. HPA Migrant Health Guide-Enteric Fevers (Typhoid and Paratyphoid). Patient information (English and other languages). Available: http://webarchive.nationalarchives.gov.uk/ 20140714084352/http://www.hpa.org.uk/MigrantHealthGuide/HealthTopics/InfectiousDiseases/EntericFevers/#Pat-info-Eng-other-languages. Accessed 02 September 2014.
26. Behrens RH, Roberts JA. Is travel prophylaxis worth while? Economic appraisal of prophylactic measures against malaria, hepatitis A, and typhoid in travellers. BMJ. 1994; 309:918-922. PMID: 7726905